RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,999,481 (Position Closed) | Filing |
| 2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Cogent Biosciences, Inc. COGT | RA CAPITAL MANAGEMENT L.P. | 5,999,481 8.600% | 2,387,274 (+66.09%) | Filing |
| 2022-09-06 4:30 pm Purchase | 2022-08-24 | 13G | Cogent Biosciences, Inc. COGT | RA CAPITAL MANAGEMENT L.P. | 3,612,207 5.490% | 3,612,207 (New Position) | Filing |